Bedaquiline resistance in patients with drug-resistant tuberculosis in Cape Town, South Africa: a retrospective longitudinal cohort study
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Bedaquiline resistance in patients with drug-resistant tuberculosis in Cape Town, South Africa: a retrospective longitudinal cohort study
Authors
Keywords
-
Journal
Lancet Microbe
Volume -, Issue -, Pages -
Publisher
Elsevier BV
Online
2023-11-04
DOI
10.1016/s2666-5247(23)00172-6
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Bedaquiline-Resistant Tuberculosis Associated with Rv0678 Mutations
- (2022) Shaheed V. Omar et al. NEW ENGLAND JOURNAL OF MEDICINE
- Bedaquiline safety, efficacy, utilization and emergence of resistance following treatment of multidrug-resistant tuberculosis patients in South Africa: a retrospective cohort analysis
- (2022) Helen Pai et al. BMC INFECTIOUS DISEASES
- Emergence of bedaquiline-resistance in a high-burden country of tuberculosis
- (2021) Elena Chesov et al. EUROPEAN RESPIRATORY JOURNAL
- Intragenic Distribution of IS 6110 in Clinical Mycobacterium tuberculosis Strains: Bioinformatic Evidence for Gene Disruption Leading to Underdiagnosed Antibiotic Resistance
- (2021) Rudy Antoine et al. Microbiology Spectrum
- Genetic variants and their association with phenotypic resistance to bedaquiline in Mycobacterium tuberculosis: a systematic review and individual isolate data analysis
- (2021) Nabila Ismail et al. Lancet Microbe
- Treatment of Highly Drug-Resistant Pulmonary Tuberculosis
- (2020) Francesca Conradie et al. NEW ENGLAND JOURNAL OF MEDICINE
- Systematic review of mutations associated with resistance to the new and repurposed Mycobacterium tuberculosis drugs bedaquiline, clofazimine, linezolid, delamanid and pretomanid
- (2020) Suha Kadura et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- World Health Organization recommendations on the treatment of drug-resistant tuberculosis, 2020 update
- (2020) Fuad Mirzayev et al. EUROPEAN RESPIRATORY JOURNAL
- Bedaquiline Microheteroresistance after Cessation of Tuberculosis Treatment
- (2019) Margaretha de Vos et al. NEW ENGLAND JOURNAL OF MEDICINE
- Acquisition of cross-resistance to Bedaquiline and Clofazimine following treatment for Tuberculosis in Pakistan
- (2019) Arash Ghodousi et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Whole genome sequencing provides additional insights into recurrent tuberculosis classified as endogenous reactivation by IS6110 DNA fingerprinting
- (2019) Anzaan Dippenaar et al. INFECTION GENETICS AND EVOLUTION
- Minority Mycobacterium tuberculosis Genotypic Populations as an Indicator of Subsequent Phenotypic Resistance
- (2019) David M. Engelthaler et al. AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY
- Long-term bedaquiline-related treatment outcomes in patients with extensively drug-resistant tuberculosis from South Africa
- (2018) Olatunde Olayanju et al. EUROPEAN RESPIRATORY JOURNAL
- Defining Bedaquiline Susceptibility, Resistance, Cross-Resistance and Associated Genetic Determinants: A Retrospective Cohort Study
- (2018) Nazir A. Ismail et al. EBioMedicine
- Bedaquiline susceptibility testing ofMycobacterium tuberculosisin an automated liquid culture system
- (2015) Gabriela Torrea et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Costs to Health Services and the Patient of Treating Tuberculosis: A Systematic Literature Review
- (2015) Yoko V. Laurence et al. PHARMACOECONOMICS
- Community-based treatment of drug-resistant tuberculosis in Khayelitsha, South Africa
- (2014) H. Cox et al. INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now